These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dapsone-resistant leprosy and its implications for leprosy control programmes. Pearson JM; Cap JA; Haile GS; Rees RJ Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000 [No Abstract] [Full Text] [Related]
4. Study of sulphone resistance in leprosy patients in India. Taylor PM; Chacko CJ; Job CK Lepr Rev; 1976 Mar; 47(1):5-11. PubMed ID: 772342 [No Abstract] [Full Text] [Related]
6. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report. Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722 [No Abstract] [Full Text] [Related]
7. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae. McDougall AC; Rees RJ Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180 [No Abstract] [Full Text] [Related]
8. Clinical assessment and management of dapsone-resistant leprosy for the field worker. Warren G Lepr Rev; 1977 Jun; 48(2):113-21. PubMed ID: 330996 [No Abstract] [Full Text] [Related]
9. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852 [No Abstract] [Full Text] [Related]
10. Dapsone-resistant leprosy in a population of Bamako (Mali). Baquillon G; Ferracci C; Saint Andre P; Pattyn SR Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500 [No Abstract] [Full Text] [Related]
11. Prevalence of secondary dapsone-resistant leprosy in Upper Volta. Pattyn SR; Yada A; Sansarricq H; van Loo L Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476 [No Abstract] [Full Text] [Related]
12. Secondary sulphone resistance in leprosy (Report of a case). Lal S; Jaganath C; Garg BR; Paneerselvam R Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542 [TBL] [Abstract][Full Text] [Related]
13. Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Pearson JM; Rees RJ; Waters MF Lancet; 1975 Jul; 2(7924):69-72. PubMed ID: 49662 [TBL] [Abstract][Full Text] [Related]
14. Does dapsone resistance really matter in the MDT era? Ji B Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
15. Dapsone-resistant leprosy in Burundi. Bourland J; Van Loo L; Pattyn SR Lepr Rev; 1983 Sep; 54(3):239-42. PubMed ID: 6355726 [No Abstract] [Full Text] [Related]
16. The prevalence of dapsone-resistant leprosy in Israel. Levy L; Rubin GS; Sheskin J Lepr Rev; 1977 Jun; 48(2):107-12. PubMed ID: 330995 [No Abstract] [Full Text] [Related]
17. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]